1992
Gastrin and colorectal cancer
Yapp R, Modlin I, Kumar R, Binder H, Dubrow R. Gastrin and colorectal cancer. Digestive Diseases And Sciences 1992, 37: 481-484. PMID: 1551333, DOI: 10.1007/bf01307566.Peer-Reviewed Original Research
1986
Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitis.
Sandle G, Hayslett J, Binder H. Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitis. Gut 1986, 27: 309. PMID: 3699552, PMCID: PMC1433405, DOI: 10.1136/gut.27.3.309.Peer-Reviewed Original ResearchConceptsActive ulcerative colitisInactive ulcerative colitisUlcerative colitisControl subjectsPharmacological dosesIntravenous administrationNet sodiumAcute ulcerative colitisAnti-inflammatory actionEffects of glucocorticoidsNet sodium absorptionColonic sodiumRectal pdAcute increaseAcute effectsColitisHydrocortisone hemisuccinateNormal subjectsPatientsGlucocorticoid hormonesSodium absorptionNet electrolyteGlucocorticoidsSimilar increaseSimilar changes
1982
Increased risk of nephrolithiasis in patients with steatorrhea
Dharmsathaphorn K, Freeman D, Binder H, Dobbins J. Increased risk of nephrolithiasis in patients with steatorrhea. Digestive Diseases And Sciences 1982, 27: 401-405. PMID: 7075427, DOI: 10.1007/bf01295647.Peer-Reviewed Original ResearchConceptsIleal diseaseRisk of nephrolithiasisIncidence of nephrolithiasisRisk factorsRelative riskLonger risk factorsSerum uric acidFecal fat analysisUrine specific gravityControl patientsAdult patientsMale patientsSerum calciumMale sexDietary oxalateSteatorrheaFecal fatPatientsNephrolithiasisDiseaseUric acidDiarrheaHyperoxaluriaRiskSex
1981
Prevalence of Nephrolithiasis in Malabsorptive Syndromes
Dharmsathaphorn K, Freeman D, Binder H, Dobbins J. Prevalence of Nephrolithiasis in Malabsorptive Syndromes. 1981, 169-172. DOI: 10.1007/978-1-4684-8977-4_28.Peer-Reviewed Original ResearchInflammatory bowel diseaseIncidence of nephrolithiasisPrevalence of nephrolithiasisUric acid stonesMalabsorptive syndromeIleal diseaseBowel diseaseCalcium oxalateDietary oxalateInsoluble calcium oxalateAcid stonesPatientsNephrolithiasisFatty acids bindColonDiseaseFatty acidsIleostomySteatorrheaResectionHyperoxaluriaSyndromeBypassPrevalenceIncidenceIntestinal Oxalate Absorption in Calcium Oxalate Stone Disease
Dobbins J, Cooper K, Lang R, Smith L, Binder H, Broadus A. Intestinal Oxalate Absorption in Calcium Oxalate Stone Disease. 1981, 775-778. DOI: 10.1007/978-1-4684-8977-4_124.Peer-Reviewed Original ResearchOxalate excretionCalcium oxalate stonesOxalate absorptionStone diseaseOxalate stonesIntestinal oxalate absorptionCalcium oxalate stone diseaseCalcium stone diseaseOxalate stone diseaseCertain patientsOxalate dietNormal subjectsPatientsExcretionSignificant increaseGreater increaseDiseaseSimilar studies
1975
Glucagon secretion in acute and chronic pancreatitis.
Donowitz M, Hendler R, Spiro H, Binder H, Felig P. Glucagon secretion in acute and chronic pancreatitis. Annals Of Internal Medicine 1975, 83: 778-81. PMID: 1200523, DOI: 10.7326/0003-4819-83-6-778.Peer-Reviewed Original ResearchConceptsAcute pancreatitisPancreatic insufficiencyAlpha-cell responsivenessChronic pancreatic insufficiencyBasal glucagon levelsPancreatic glucagon concentrationsInfusion of alaninePrevious pancreatitisGlucagon responseAcute episodeGlucagon levelsGlucagon secretionChronic pancreatitisPlasma glucagonGlucagon concentrationsInitial episodeHealthy controlsPancreatitisCell responsivenessPatientsBasal statePrevious attacksSensitive indexInitial attackInsufficiencyA Controlled Evaluation of Intravenous Adrenocorticotropic Hormone and Hydrocortisone in the Treatment of Acute Colitis
Kaplan H, Portnoy B, Binder H, Amatruda T, Spiko H. A Controlled Evaluation of Intravenous Adrenocorticotropic Hormone and Hydrocortisone in the Treatment of Acute Colitis. Gastroenterology 1975, 69: 91-95. PMID: 168121, DOI: 10.1016/s0016-5085(19)32640-x.Peer-Reviewed Original ResearchConceptsIntravenous adrenocorticotropic hormoneAdrenocorticotropic hormoneSymptomatic inflammatory bowel diseaseSystemic steroid levelsInflammatory bowel diseaseDouble-blind techniqueTreatment of patientsConsecutive hospital patientsPlasma cortisol levelsIntravenous hydrocortisoneTherapeutic lagAcute colitisBowel diseasePatient evaluationHospital patientsDrug dosesControlled EvaluationEquivalent dosageSteroid levelsCortisol levelsExcretion rateDrug selectionHydrocortisonePatientsBlind technique
1974
Intestinal Oxalate Absorption
Binder H. Intestinal Oxalate Absorption. Gastroenterology 1974, 67: 441-446. PMID: 4852527, DOI: 10.1016/s0016-5085(19)32846-x.Peer-Reviewed Original ResearchConceptsOxalate absorptionIntestinal oxalate absorptionIntestinal oxalate transportIleal diseaseIleal dysfunctionDietary oxalateIntestinal absorptionMucosal accumulationRabbit ileumUptake of oxalateRat duodenumNonsaturable processOxalate solubilityIleumOxalate transportMetabolic inhibitorsRate of uptakeUptakePatientsHyperoxaluriaActive transportOxalate concentrationCholestyramineDysfunctionDuodenum
1966
Intolerance to milk in ulcerative colitis
Binder H, Gryboski J, Thayer W, Spiro H. Intolerance to milk in ulcerative colitis. Digestive Diseases And Sciences 1966, 11: 858-864. PMID: 6012544, DOI: 10.1007/bf02233942.Peer-Reviewed Original Research